Albion Financial Group’s CVS Health CVS Stock Holding History

Albion Financial Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76K	Sell	17 -43	-72%	-$3.84K	﹤0.01%	555
2026 Q1	$4.31K	Buy	60 +43	+253%	+$3.31K	﹤0.01%	497
2025 Q4	$1.35K	Hold	17	–	–	﹤0.01%	574
2025 Q3	$1.28K	Hold	17	–	–	﹤0.01%	570
2025 Q2	$1.17K	Hold	17	–	–	﹤0.01%	516
2025 Q1	$1.15K	Hold	17	–	–	﹤0.01%	527
2024 Q4	$764	Buy	+17	New	+$954	﹤0.01%	627
2024 Q1	–	Sell	-24	Closed	-$1.9K	–	506
2023 Q4	$1.9K	Buy	+24	New	+$1.71K	﹤0.01%	400
2023 Q1	–	Sell	-10	Closed	-$932	–	454
2022 Q4	$932	Buy	+10	New	+$965	﹤0.01%	432
2022 Q3	–	Sell	-13	Closed	-$1K	–	462
2022 Q2	$1K	Sell	13 -73	-85%	-$7.13K	﹤0.01%	455
2022 Q1	$8K	Sell	86 -255	-75%	-$26.8K	﹤0.01%	379
2021 Q4	$35K	Sell	341 -141	-29%	-$13K	﹤0.01%	309
2021 Q3	$41K	Hold	482	–	–	﹤0.01%	265
2021 Q2	$40K	Buy	+482	New	+$39.5K	﹤0.01%	272
2020 Q4	$35K	Buy	+515	New	+$33.5K	﹤0.01%	266

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Albion Financial Group's CVS Position: Q2 2026 in Review

Albion Financial Group reduced its CVS Health (CVS) stake by 72% in Q2 2026, selling an estimated $3.84K and leaving 17 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Albion Financial Group first reported a position in CVS in Q4 2020 and has held it in 15 quarters since. The position peaked at $41K in Q3 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Albion Financial Group held 17 shares of CVS Health worth $1.76K as of Q2 2026.
Albion Financial Group sold 43 CVS Health shares in Q2 2026, an estimated $3.84K.
CVS Health made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #555 holding.
Albion Financial Group first reported a position in CVS Health in Q4 2020 and has held it in 15 quarters since.
Albion Financial Group's CVS Health position peaked at $41K in Q3 2021.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.